Treatment Modalities to Improve Response in Tumors Refractory to Standard Immunotherapy Approaches
Time: 12:30 pm
day: Preclinical Track - Day 1 am
Details:
- Low dose radiation in combination with immunotherapy in advanced tumors
- Mechanistic insights into radioimmunotherapy resistance
- Reversing immune dysfunction via interference of TGFbeta pathway with inhibitors of the integrin avB8
